Content-Type: multipart/alternative; boundary="----=_NextPart_59956495.694656944196" X-Msg2Mime: True X-Msg2Mime-Client-Submit-Time: Thu, 02 Apr 2015 13:00:18 -0400 X-Msg2Mime-Message-Delivery-Time: Thu, 02 Apr 2015 13:00:24 -0400 X-Msg2Mime-Creation-Time: Tue, 17 May 2016 14:34:32 -0400 Received: from DM2PR0201MB0847.namprd02.prod.outlook.com (25.160.95.156) by BN1PR0201MB0836.namprd02.prod.outlook.com (25.160.170.156) with Microsoft SMTP Server (TLS) id 15.1.130.23 via Mailbox Transport; Thu, 2 Apr 2015 17:00:23 +0000 Received: from CY1PR0201CA0018.namprd02.prod.outlook.com (25.163.30.156) by DM2PR0201MB0847.namprd02.prod.outlook.com (25.160.95.156) with Microsoft SMTP Server (TLS) id 15.1.125.19; Thu, 2 Apr 2015 17:00:22 +0000 Received: from BY2FFO11FD035.protection.gbl (2a01:111:f400:7c0c::146) by CY1PR0201CA0018.outlook.office365.com (2a01:111:e400:58b9::28) with Microsoft SMTP Server (TLS) id 15.1.130.23 via Frontend Transport; Thu, 2 Apr 2015 17:00:22 +0000 Authentication-Results: spf=none (sender IP is 142.103.117.139) smtp.mailfrom=botany.ubc.ca; uga.edu; dkim=none (message not signed) header.d=none;uga.edu; dmarc=none action=none header.from=botany.ubc.ca; Received-SPF: None (protection.outlook.com: botany.ubc.ca does not designate permitted sender hosts) Received: from vmaprod5.mail-relay.ubc.ca (142.103.117.139) by BY2FFO11FD035.mail.protection.outlook.com (10.1.14.220) with Microsoft SMTP Server (TLS) id 15.1.136.16 via Frontend Transport; Thu, 2 Apr 2015 17:00:21 +0000 Received: from vmaprod5.mail-relay.ubc.ca (localhost.localdomain [127.0.0.1]) by localhost (Email Security Appliance) with SMTP id 4662F27C87D_51D75A4B; Thu, 2 Apr 2015 17:00:20 +0000 (GMT) Received: from mx2.mail-relay.ubc.ca (lb_mx-out.mail-relay.ubc.ca [10.92.8.24]) (using TLSv1.2 with cipher ECDHE-RSA-AES256-GCM-SHA384 (256/256 bits)) (Client CN "mx2.mail-relay.ubc.ca", Issuer "mx2.mail-relay.ubc.ca" (not verified)) by vmaprod5.mail-relay.ubc.ca (Sophos Email Appliance) with ESMTPS id CDD0527C8B0_51D75A3F; Thu, 2 Apr 2015 17:00:19 +0000 (GMT) Received: from smtp.mail.ubc.ca (s-itsv-hub04p.ead.ubc.ca [137.82.151.86]) (using TLSv1 with cipher AES128-SHA (128/128 bits)) (Client CN "rpc.mail.ubc.ca", Issuer "Entrust Certification Authority - L1K" (not verified)) by mx2.mail-relay.ubc.ca (Postfix) with ESMTPS id 7B4B315F92F; Thu, 2 Apr 2015 10:00:20 -0700 (PDT) Received: from S-ITSV-MBX05P.ead.ubc.ca ([169.254.12.161]) by s-itsv-hub04p.ead.ubc.ca ([137.82.151.86]) with mapi id 14.03.0210.002; Thu, 2 Apr 2015 10:00:19 -0700 From: "Rieseberg, Loren" To: Sandy Wiggins CC: "john burke:" , Alison Dendoff , Megan Stewart , Emily Marden Subject: Re: LSARP2014 Meeting Dates and Info Thread-Topic: LSARP2014 Meeting Dates and Info Thread-Index: AdBstNrMOIBYlJUnSTOMgvVTTtvhagA7FASA Date: Thu, 2 Apr 2015 17:00:18 +0000 Message-ID: <665773CC-D2C9-4919-9EA3-33762F2B885E@mail.ubc.ca> References: <1DFDE431FA89BE4E82788D9D51E72029146CB103@JUPITER.ms.genomebc.ca> In-Reply-To: <1DFDE431FA89BE4E82788D9D51E72029146CB103@JUPITER.ms.genomebc.ca> Accept-Language: en-US, en-CA Content-Language: en-US X-MS-Has-Attach: X-MS-TNEF-Correlator: x-originating-ip: [128.189.238.24] MIME-Version: 1.0 Return-Path: loren.rieseberg@botany.ubc.ca X-MS-Exchange-Organization-Network-Message-Id: 70660a21-7b97-4b60-07bf-08d23b7da3d9 X-EOPAttributedMessage: 0 X-MS-Exchange-Organization-MessageDirectionality: Incoming X-Forefront-Antispam-Report: CIP:142.103.117.139;CTRY:CA;IPV:NLI;EFV:NLI;SFV:NSPM;SFS:(6009001)(428002)(51164003)(189002)(199003)(24454002)(377454003)(51704005)(76176999)(54356999)(5890100001)(83716003)(46102003)(2656002)(6806004)(19580395003)(19580405001)(87836001)(74482002)(92566002)(36756003)(2900100001)(102836002)(2950100001)(33656002)(561944003)(62966003)(450100001)(82746002)(86362001)(105586002)(106466001)(77156002)(23746002)(53416004)(50986999)(47776003)(50466002)(66066001)(110136001)(7059030)(104396002);DIR:INB;SFP:;SCL:1;SRVR:DM2PR0201MB0847;H:vmaprod5.mail-relay.ubc.ca;FPR:;SPF:None;MLV:sfv;MX:1;A:1;LANG:en; X-Microsoft-Antispam: UriScan:;BCL:0;PCL:0;RULEID:;SRVR:DM2PR0201MB0847; X-MS-Exchange-Organization-AVStamp-Service: 1.0 X-Exchange-Antispam-Report-Test: UriScan:; X-Exchange-Antispam-Report-CFA-Test: BCL:0;PCL:0;RULEID:(601004);SRVR:DM2PR0201MB0847;BCL:0;PCL:0;RULEID:;SRVR:DM2PR0201MB0847; X-MS-Exchange-Organization-SCL: 1 X-MS-Exchange-CrossTenant-OriginalArrivalTime: 02 Apr 2015 17:00:21.5245 (UTC) X-MS-Exchange-CrossTenant-Id: a8216c1e-4d63-4352-8c3b-50fa1f1475b1 X-MS-Exchange-CrossTenant-FromEntityHeader: Internet X-MS-Exchange-Transport-CrossTenantHeadersStamped: DM2PR0201MB0847 X-MS-Exchange-Organization-AuthSource: BY2FFO11FD035.protection.gbl X-MS-Exchange-Organization-AuthAs: Anonymous X-MS-Exchange-Transport-EndToEndLatency: 00:00:02.5897602 ------=_NextPart_59956495.694656944196 Content-Type: text/plain; charset="utf-8" Content-Transfer-Encoding: quoted-printable Hi Sandy, We would prefer the Friday 11 am slot. Our second choice is 8 am Friday. thanks, loren On Apr 1, 2015, at 12:56 PM, Sandy Wiggins wrote: > Dear Rieseberg/Burke Team, > > Your Face-to-Face Full Application Review Meeting with Genome Canada=E2= =80=99s International Scientific Review Committee at the Intercontinental T= oronto Yorkville Hotel has been set for Thursday, May 28th from 10:05AM to= 11:55AM. Accommodations at a nearby hotel are being held for you by Genom= e BC. All other travel related info will be communicated in due course. > > In preparation for this meeting we need to now confirm your mock meeting = (practice session) at the Genome BC offices on either Thursday, May 14th or= Friday, May 15th. The mock interview is designed to imitate the actual Fa= ce-to-Face meeting. The Project Leader will give a 10 minute presentation w= hich will be followed by a Q&A session. After that you will be challenged o= n your presentation, scientific merit and benefits to Canada. > > Mock Meeting (May 14 or 15) > We will do our best to accommodate everyone=E2=80=99s schedules but we ca= nnot guarantee first choice. Please indicate your first and second choice f= or times on the following available slots. > > Thursday, May 14th: > 11AM-1:30PM > > Friday, May 15th: > 8AM-10:30AM > 11AM-1:30PM > 2PM-430PM > > Each project has been scheduled for 2.5 hours, (a 90-minute simulation of= the actual interview and the remainder for critical comments and suggestio= ns for improvement). This time will include: > > =E2=80=A2 10-minute discussion by the committee before the re= presentatives and observers enter the room > =E2=80=A2 5 minutes for introduction > =E2=80=A2 10-minute presentation (max.) by the presenter for = the project (see presentation instructions below) > =E2=80=A2 60 minutes Q&A period > =E2=80=A2 5 minutes break > =E2=80=A2 60 minutes for critical comments and suggestions fo= r improvement > > Participants > Each project may be represented by a maximum of five individuals. Only o= ne person may make the presentation for each project; other representatives= are present in order to respond to questions from the committee. The team= representatives for the mock session at Genome BC should be the same as th= e participants who plan to attend the meeting at Genome Canada. Please fil= l out the attached Participant table and return to us by April 20th. Pleas= e advise who will be travelling to the GBC mock review panel meeting. > > Presentation > Please prepare a PowerPoint presentation of your proposal that you can co= mplete in 10 minutes. Timing is critical. We suggest a limit of 10 slides w= ith no animations. Please keep the following in mind: > > 1. The presentation should not be a recap of the proposal. > 2. The reviewers have read the proposal and the presentation should= only be an update to highlight the proposals and to inform the reviewers o= n any changes to approaches or co-funding. > 3. A slide should be devoted to how the project will be managed. > 4. End the presentation with a slide on Benefits to Canada. > 5. Number each slide for easy reference by the reviewers. > > Please bring a back-up of your presentation on a memory stick to both the= mock meeting and the Genome Canada meeting. > > Please email your presentation to Alison Dendoff (adendoff@genomebc.ca) = by Friday, May 8, 2015. > > Best regards, Sandy (for Alison) > <2014 LSARP List of Participants for Face-to-Face Meetings_for Team_SW.do= cx> Loren Rieseberg Botany Department University of British Columbia 3529-6270 University Blvd Vancouver, B.C. V6T 1Z4 Phone: 604-827-4540 Fax: 604-822-6089 ------=_NextPart_59956495.694656944196 Content-Type: text/rtf; charset="utf-8" Content-Transfer-Encoding: quoted-printable {\rtf1\ansi\ansicpg1252\fromtext \fbidis \deff0{\fonttbl=0A=0D{\f0\fswiss\f= charset0 Arial;}=0A=0D{\f1\fmodern Courier New;}=0A=0D{\f2\fnil\fcharset2 S= ymbol;}=0A=0D{\f3\fmodern\fcharset0 Courier New;}}=0A=0D{\colortbl\red0\gre= en0\blue0;\red0\green0\blue255;}=0A=0D\uc1\pard\plain\deftab360 \f0\fs20 Hi= Sandy,\par=0A=0D\par=0A=0DWe would prefer the Friday 11 am slot. Our seco= nd choice is 8 am Friday.\par=0A=0D\par=0A=0Dthanks, loren\par=0A=0D\par=0A= =0DOn Apr 1, 2015, at 12:56 PM, Sandy Wiggins wrote:= \par=0A=0D\par=0A=0D> Dear Rieseberg/Burke Team,\par=0A=0D> \par=0A=0D> Yo= ur Face-to-Face Full Application Review Meeting with Genome Canada\'92s Int= ernational Scientific Review Committee at the Intercontinental Toronto York= ville Hotel has been set for Thursday, May 28th from 10:05AM to 11:55AM. = Accommodations at a nearby hotel are being held for you by Genome BC. All o= ther travel related info will be communicated in due course.\par=0A=0D> \p= ar=0A=0D> In preparation for this meeting we need to now confirm your mock = meeting (practice session) at the Genome BC offices on either Thursday, May= 14th or Friday, May 15th. The mock interview is designed to imitate the a= ctual Face-to-Face meeting. The Project Leader will give a 10 minute presen= tation which will be followed by a Q&A session. After that you will be chal= lenged on your presentation, scientific merit and benefits to Canada.\par= =0A=0D> \par=0A=0D> Mock Meeting (May 14 or 15)\par=0A=0D> We will do our = best to accommodate everyone\'92s schedules but we cannot guarantee first c= hoice. Please indicate your first and second choice for times on the follow= ing available slots.\par=0A=0D> \par=0A=0D> Thursday, May 14th:\par=0A=0D>= 11AM-1:30PM\par=0A=0D> \par=0A=0D> Friday, May 15th:\par=0A=0D> 8AM-10:30= AM\par=0A=0D> 11AM-1:30PM\par=0A=0D> 2PM-430PM\par=0A=0D> \par=0A=0D> Each= project has been scheduled for 2.5 hours, (a 90-minute simulation of the a= ctual interview and the remainder for critical comments and suggestions for= improvement). This time will include:\par=0A=0D> \par=0A=0D> \'95 = 10-minute discussion by the committee before the representatives and o= bservers enter the room\par=0A=0D> \'95 5 minutes for introduct= ion\par=0A=0D> \'95 10-minute presentation (max.) by the presen= ter for the project (see presentation instructions below)\par=0A=0D> \'95 = 60 minutes Q&A period\par=0A=0D> \'95 5 minutes brea= k\par=0A=0D> \'95 60 minutes for critical comments and suggesti= ons for improvement\par=0A=0D> \par=0A=0D> Participants\par=0A=0D> Each pr= oject may be represented by a maximum of five individuals. Only one person= may make the presentation for each project; other representatives are pres= ent in order to respond to questions from the committee. The team represen= tatives for the mock session at Genome BC should be the same as the partici= pants who plan to attend the meeting at Genome Canada. Please fill out the= attached Participant table and return to us by April 20th. Please advise = who will be travelling to the GBC mock review panel meeting.\par=0A=0D> \p= ar=0A=0D> Presentation\par=0A=0D> Please prepare a PowerPoint presentation = of your proposal that you can complete in 10 minutes. Timing is critical. W= e suggest a limit of 10 slides with no animations. Please keep the followin= g in mind:\par=0A=0D> \par=0A=0D> 1. The presentation should not be = a recap of the proposal.\par=0A=0D> 2. The reviewers have read the pr= oposal and the presentation should only be an update to highlight the propo= sals and to inform the reviewers on any changes to approaches or co-funding= .\par=0A=0D> 3. A slide should be devoted to how the project will be = managed.\par=0A=0D> 4. End the presentation with a slide on Benefits to = Canada.\par=0A=0D> 5. Number each slide for easy reference by the review= ers.\par=0A=0D> \par=0A=0D> Please bring a back-up of your presentation on= a memory stick to both the mock meeting and the Genome Canada meeting.\par= =0A=0D> \par=0A=0D> Please email your presentation to Alison Dendoff (ade= ndoff@genomebc.ca) by Friday, May 8, 2015.\par=0A=0D> \par=0A=0D> Best re= gards, Sandy (for Alison)\par=0A=0D> <2014 LSARP List of Participants for F= ace-to-Face Meetings_for Team_SW.docx>\par=0A=0D\par=0A=0DLoren Rieseberg\p= ar=0A=0DBotany Department\par=0A=0DUniversity of British Columbia\par=0A=0D= 3529-6270 University Blvd\par=0A=0DVancouver, B.C. V6T 1Z4\par=0A=0DPhone: = 604-827-4540\par=0A=0DFax: 604-822-6089\par=0A=0D\par=0A=0D} ------=_NextPart_59956495.694656944196--